1 duplicate copy in the archive
EFTA Document EFTA01457563
Title Matchefta-efta01457563
Case Filesd-10-EFTA01457563Dept. of JusticeEFTA Document EFTA01457563
Unknown1p
Case File
sd-10-EFTA01457563Dept. of JusticeEFTA Document EFTA01457563
Other
II May 2015 Pharmaceuticals GlazeSmithKline [Figure 14: Core P&L forecasts G(iPm Sales Growth I%) FYI4A 23.000 -10.1% rr Hi( 24,402 6.1% f-Y16E 26,919 3.7% F't i 7l: 26.105 3.1% F, i I SE 28,797 2.7% 819E 27.247 1.7% i Y20( 29.217 3.6% ...Pharmaceuticals 18.670 18,184 18,456 18,979 19,386 19,546 20.218 ...Consumer Health 4.336 6,218 6,868 7.128 7,412 7.701 7.999 Cost of sales -6.535 -7,985 -8,179 -8.477 -8.956 -9,088 8,315 Gross Profit 16,471
Date
Unknown
Source
Dept. of Justice
Reference
sd-10-EFTA01457563
Pages
1
Persons
0
Integrity
Loading document viewer...
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,800+ persons in the Epstein files. 100% free, donor-supported, and independent. Donors see no ads.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.